Researchers have identified a biological mechanism that helps explain why some lung and ovarian cancers become resistant to chemotherapy, offering insight into why cancers recur. The study, published in Nature Aging this month, investigated how platinum-based chemotherapies such as cisplatin negatively affect tumor behavior in non-small cell lung cancer (NSCLC) and high-grade serous ovarian cancer (HGSOC). Although these treatments are widely used, their long-term effectiveness is often limited when tumors return or stop responding.
This article was originally published on MedicalXpress.com
